ANGO | AngioDynamics, Inc.

Index- P/E- EPS (ttm)-0.95 Insider Own3.10% Shs Outstand39.51M Perf Week6.51%
Market Cap378.24M Forward P/E998.00 EPS next Y0.01 Insider Trans-0.39% Shs Float37.14M Perf Month15.11%
Income-37.20M PEG- EPS next Q-0.07 Inst Own96.30% Short Float / Ratio2.05% / 2.25 Perf Quarter-20.22%
Sales334.70M P/S1.13 EPS this Y17.30% Inst Trans-0.28% Short Interest0.76M Perf Half Y-22.93%
Book/sh10.06 P/B0.99 EPS next Y120.00% ROA-6.70% Target Price15.50 Perf Year-49.26%
Cash/sh0.79 P/C12.57 EPS next 5Y15.00% ROE-9.10% 52W Range8.18 - 24.74 Perf YTD-27.52%
Dividend- P/FCF- EPS past 5Y-28.70% ROI-5.60% 52W High-59.66% Beta0.60
Dividend %- Quick Ratio1.30 Sales past 5Y3.20% Gross Margin52.10% 52W Low22.00% ATR0.38
Employees760 Current Ratio2.20 Sales Q/Q9.10% Oper. Margin-11.00% RSI (14)63.41 Volatility4.31% 3.54%
OptionableYes Debt/Eq0.13 EPS Q/Q-89.30% Profit Margin-11.10% Rel Volume1.28 Prev Close9.64
ShortableYes LT Debt/Eq0.13 EarningsMar 30 BMO Payout- Avg Volume338.67K Price9.98
Recom2.20 SMA206.93% SMA504.50% SMA200-28.07% Volume432,640 Change3.53%
Date Action Analyst Rating Change Price Target Change
Apr-17-23Downgrade Raymond James Strong Buy → Outperform $14 → $13
Oct-15-21Upgrade Canaccord Genuity Hold → Buy $28 → $37
Aug-20-21Initiated Oppenheimer Perform
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
May-18-23 07:39AM
May-16-23 09:12AM
May-15-23 09:41AM
Apr-26-23 08:00PM
08:29AM Loading…
Apr-17-23 08:29AM
Apr-14-23 09:17AM
Apr-11-23 04:01PM
Apr-10-23 08:30AM
Apr-04-23 09:53AM
Apr-01-23 12:09PM
Mar-31-23 07:38PM
Mar-30-23 08:15AM
Mar-18-23 09:02AM
04:01PM Loading…
Mar-13-23 04:01PM
Feb-28-23 08:00AM
Jan-24-23 12:43PM
Jan-19-23 10:23AM
Jan-10-23 07:28AM
Jan-09-23 05:12AM
Jan-06-23 09:03AM
Jan-05-23 05:27PM
Dec-30-22 11:33AM
Dec-22-22 09:06AM
Dec-20-22 04:01PM
Dec-15-22 04:01PM
08:29AM Loading…
Nov-25-22 08:29AM
Nov-17-22 04:01PM
Oct-31-22 04:01PM
Oct-29-22 08:41AM
Oct-21-22 09:20AM
Oct-10-22 11:19AM
Oct-09-22 08:10AM
Oct-06-22 10:58AM
Sep-22-22 01:00PM
Sep-08-22 04:01PM
Aug-31-22 11:16AM
Aug-11-22 11:30AM
Aug-10-22 08:35AM
Aug-03-22 04:01PM
Jul-29-22 06:55AM
Jul-25-22 05:07PM
Jul-14-22 08:27AM
Jul-13-22 02:51PM
Jul-12-22 08:25AM
Jun-28-22 08:00AM
Jun-15-22 04:01PM
May-16-22 04:01PM
May-03-22 04:01PM
May-02-22 07:02AM
May-01-22 08:15AM
Apr-08-22 10:00AM
Apr-07-22 12:54PM
Apr-04-22 04:01PM
Mar-14-22 04:01PM
Mar-08-22 06:30PM
Mar-02-22 03:23PM
Feb-08-22 04:01PM
Feb-02-22 09:38AM
Feb-01-22 07:47AM
Jan-20-22 04:25AM
Jan-12-22 12:11PM
Jan-07-22 10:51AM
Jan-06-22 04:42PM
Jan-03-22 04:01PM
Dec-30-21 03:00PM
Dec-15-21 04:01PM
Nov-29-21 11:15AM
Nov-26-21 02:21PM
Nov-25-21 07:55AM
Nov-24-21 09:40AM
Nov-18-21 10:31AM
Nov-16-21 11:04AM
Nov-12-21 09:36AM
Nov-11-21 10:48AM
Nov-10-21 07:32AM
Nov-09-21 09:54AM
Nov-08-21 10:18AM
Nov-05-21 10:34AM
Nov-04-21 07:55AM
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Helsel DaveSVP Global Operations and R&DJan 31Sale12.954,63359,99719,189Feb 01 04:07 PM
Trowbridge Stephen AEVP and CFOOct 12Buy13.821,08314,96789,581Oct 12 05:23 PM
Clemmer James CPresident and CEOOct 10Buy15.0010,000150,000450,407Oct 11 04:06 PM
Helsel DaveSVP Global Operations and R&DJul 29Sale22.445,000112,20023,822Aug 01 04:19 PM
Trowbridge Stephen AEVP and CFOJul 15Option Exercise15.9514,758235,39092,935Jul 18 04:13 PM
JOHNSON WESLEYDirectorJul 15Option Exercise15.956,02296,05185,726Jul 18 04:16 PM
Meteny Dennis SDirectorJul 12Option Exercise15.956,02296,051120,716Jul 14 04:15 PM
Helsel DaveSVP Global Operations and R&DJul 07Option Exercise0.003,480026,354Jul 11 06:20 AM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 07Option Exercise0.003,104034,845Jul 11 06:17 AM
Nighan Warren JRSVP Quality and RegulatoryJul 07Option Exercise0.003,233037,112Jul 11 06:15 AM
Trowbridge Stephen AEVP and CFOJul 07Option Exercise0.004,188079,686Jul 11 06:12 AM
Clemmer James CPresident and CEOJul 07Option Exercise0.0025,1230415,887Jul 11 06:08 AM